gadolinium has been researched along with Glioblastoma in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.11) | 18.7374 |
1990's | 10 (11.11) | 18.2507 |
2000's | 12 (13.33) | 29.6817 |
2010's | 52 (57.78) | 24.3611 |
2020's | 15 (16.67) | 2.80 |
Authors | Studies |
---|---|
Baloglu, S; Cebula, H; Chibbaro, S; De Mathelin, M; Gangi, A; Mallereau, CH; Noblet, V; Noel, G; Proust, F; Todeschi, J | 1 |
Bona, M; Kirchin, MA; Kuhn, MJ; Patriarche, D; Patriarche, JW; Pirovano, G | 1 |
Bendszus, M; Brandes, AA; Brugnara, G; Debus, J; Foltyn, M; Gorlia, T; Heiland, S; Idbaih, A; Isensee, F; Jayachandran Preetha, C; Kessler, T; Mahmutoglu, MA; Maier-Hein, KH; Meredig, H; Nabors, B; Neuberger, U; Petersen, J; Pflüger, I; Platten, M; Schell, M; Stupp, R; Tonn, JC; van den Bent, MJ; Vollmuth, P; Weller, M; Wick, A; Wick, W; Winkler, F | 1 |
Glenn, CA; Javan, R; Johnson, DR; Olson, JJ | 1 |
Bauser, M; Berger, M; Ebert, W; Frenzel, T; Hilger, CS; Jost, G; Lohrke, J; Panknin, O; Pietsch, H | 1 |
Lespinasse, E; Rojas, R; Sarkar, S; Zeron, R; Zhang, XF | 1 |
Chen, SY; Cheng, HW; Chiang, CS; Chu, CY; Jeng, LB; Lai, YH; Shyu, WC; Su, CY | 1 |
Bazzi, R; Chastagner, P; Chateau, A; Devy, J; Durand, M; Jubréaux, J; Laurent, G; Paquot, H; Pinel, S; Reinhard-Ruch, A; Richet, N; Roux, S | 1 |
Bartel, J; Becher, D; Hadlich, S; Ittermann, T; Kromrey, ML; Kühn, JP; Mouchantat, S; Oswald, S; Paland, H; Schulze, J | 1 |
Fukushima, M; Inoue, A; Kitazawa, R; Kohno, S; Kunieda, T; Kurata, M; Matsumoto, S; Nishikawa, M; Ohnishi, T; Ohue, S; Ozaki, S; Shigekawa, S; Suehiro, S; Watanabe, H | 1 |
Atenafu, EG; Campbell, M; Chen, H; Das, S; Detsky, J; Ho, L; Husain, Z; Lau, AZ; Lee, Y; Lipsman, N; Maralani, PJ; Myrehaug, S; Perry, J; Ruschin, M; Sahgal, A; Soliman, H; Stanisz, G; Stewart, J; Tseng, CL | 1 |
Acherar, S; Barberi-Heyob, M; Chateau, A; Choulier, L; Daouk, J; Frochot, C; Gries, M; Jouan-Hureaux, V; Jubréaux, J; Lux, F; Pierson, J; Reinhard, A; Rocchi, P; Thomas, N; Tillement, O | 1 |
Chikui, T; Hata, N; Hiwatashi, A; Iihara, K; Kami, Y; Kikuchi, K; Kikuchi, Y; Kuga, D; Mizoguchi, M; Momosaka, D; Togao, O; Tokumori, K | 1 |
Hall, AJ; Hill, LR; Rendina, LM; Robertson, AG | 1 |
Fujioka, Y; Funakoshi, Y; Hata, N; Hatae, R; Hiwatashi, A; Kuga, D; Michiwaki, Y; Mizoguchi, M; Otsuji, R; Sako, A; Sangatsuda, Y; Takigawa, K; Togao, O; Yonezawa, H; Yoshimoto, K; Yoshiura, T | 1 |
Adle-Biassette, H; Amelot, A; Badoual, M; Carpentier, AF; Deroulers, C; Froelich, S; Houdart, E; Mandonnet, E; Polivka, M | 1 |
Gralla, J; Heldner, MR; Kamm, CP; Kellner-Weldon, F; Locher, C; Raabe, A; Schucht, P; Slotboom, J; Verma, RK; Wiest, R | 1 |
Ahmad, SB; Keller, BM; Kim, A; Pang, G; Paudel, MR; Ruschin, M; Sahgal, A; Sarfehnia, A | 1 |
Choi, SH; Kang, KM; Kim, JH; Lim, WH; Sohn, CH; Yoo, RE; Yun, TJ | 1 |
Anderson, CE; Brady-Kalnay, S; Flask, CA; Griswold, MA; Gu, Y; Hu, H; Jiang, Y; Johansen, ML; Liu, Y; Ma, D; Ramos-Estebanez, C; Wang, CY; Yu, X | 1 |
Guo, X; Hansen, MR; McCreary, M; Okuda, DT; Pan, E; Pinho, MC; Stanley, T; Wang, Y; Wilson, A | 1 |
Lupo, JM; Nelson, SJ; Park, I | 1 |
Ambady, P; Barajas, RF; Cetas, JS; Ciporen, J; Dogan, A; Firkins, J; Hamilton, BE; Han, SJ; Horvath, A; Jaboin, JJ; Kubicky, CD; McConnell, HL; Muldoon, LL; Neuwelt, EA; Pettersson, DR; Raslan, AM; Rooney, WD; Schwartz, D; Szidonya, L; Varallyay, CG; Woltjer, R | 1 |
Asano, Y; Ikegame, Y; Iwama, T; Kawasaki, T; Miwa, K; Shinoda, J; Takei, H; Yano, H; Yokoyama, K | 1 |
Barnes, A; Bisdas, S; Brandner, S; Endozo, R; Ganeshan, B; Groves, A; Jaunmuktane, Z; Lewis, MA; Thust, SC | 1 |
Koch, R; Müther, M; Schwindt, W; Sporns, P; Stummer, W; Weckesser, M | 1 |
Akiyama, Y; Awai, K; Hashizume, A; Kaichi, Y; Karlowee, V; Kolakshyapati, M; Kurisu, K; Maruyama, H; Ochi, K; Sugiyama, K; Takano, M; Takayasu, T; Ueno, H; Yamasaki, F | 1 |
Akutsu, H; Ishikawa, E; Kimu, H; Matsuda, M; Matsumura, A; Nakai, K; Osuka, S; Takano, S; Tsuda, K; Yamamoto, T | 1 |
Furuse, M; Hiramatsu, R; Kawabata, S; Kuroiwa, T; Miyatake, S | 1 |
Benard, F; Chan, EK; Cheung, A; Hsu, F; Kosztyla, R; Ma, R; Moiseenko, V; Nichol, A; Wilson, D; Zhang, S | 1 |
Date, I; Ichikawa, T; Kurozumi, K; Onoda, K; Yanai, H; Yoshida, K | 1 |
Aygun, N; Kalkanis, SN; Morris, J; Nair, R; Olson, JJ; Ryken, TC; Schweizer, M; Spracklen, C | 1 |
Anderson, CM; Bayouth, JE; Buatti, JM; Capizzano, AA; Clerkin, PP; Magnotta, V; McGuire, SM; Morris, A; Muruganandham, M; Smith, BJ; Smith, MC | 1 |
Bakshi, KS; Chen, Y; Davis, RM; Dorn, HC; Eltahir, A; Karolyi, DR; Kiselev, B; LaConte, SM; Li, T; Madsen, LA; Morris, JR; Murphy, S; Sheng, Z; Zhang, J; Zhang, Y; Zhu, J | 1 |
de Nijs, R; Dyssegaard, A; Feng, L; Fischer, W; Guilloteau, D; Jensen, P; Knudsen, GM; Larsen, VA; Law, I; Mikkelsen, JD; Pinborg, LH; Svarer, C; Thomsen, G | 1 |
Easaw, JC; Sayeed, WM; Singh, AD | 1 |
Auer, DP; Jamjoom, AA; Manita, MA; Rajeb, AT; Rodriguez, D; Shah, KA | 1 |
Alberich-Bayarri, A; Blasco, G; Daunis-I-Estadella, J; Essig, M; Hernández, D; Jain, R; Mateu, G; Pedraza, S; Puig, J; Puigdemont, M; Remollo, S; Sánchez-González, J; Wintermark, M | 1 |
Ardenkjaer-Larsen, JH; Kadambi, A; Lupo, JM; Nelson, SJ; Park, I; Vigneron, DB; von Morze, C | 1 |
Bu, W; Liu, J; Ni, D; Shen, Z; Shi, J; Wang, J; Wu, R; Yao, Z; Yi, M; Zhang, C; Zhang, J | 1 |
Braun, KA; Davis, WC; Herring, MN; Lindhorst, SM; Maravilla, KR; Roberts, DR; Thiers, BH; Welsh, CT | 1 |
Depeš, D; Falk, M; Kozubek, S; Lacombe, S; Lux, F; Pagáčová, E; Porcel, E; Salado, D; Štefančíková, L; Tillement, O | 1 |
Gonen, T; Grossman, R; Harosh, CB; Kimchi, TJ; Ram, Z; Shimony, N; Shir, D; Sitt, R | 1 |
Bonnet-Boissinot, S; Carmona, A; L'Homel, B; Ortega, R; Pouzoulet, F; Prezado, Y; Roudeau, S | 1 |
Andorf, C; Kroc, T; Lennox, A; Saroja, KR; Schneider, L; Yasui, LS | 1 |
Adamsen, TC; Chakraborty, G; Harpold, HL; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR; Wang, CH | 1 |
Hofer, S; Kollias, S; Weller, M | 1 |
Alvord, EC; Chakraborty, G; Hadley, J; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR; Szeto, MD | 1 |
Beattie, BJ; Blasberg, RG; Holodny, AI; Makeyev, S; Riad, S | 1 |
Gahramanov, S; Haluska, M; Hamilton, BE; Muldoon, LL; Neuwelt, EA; Njus, JM; Raslan, AM; Rooney, WD; Varallyay, CG | 1 |
Guiot, MC; Kalokhe, U; Macdonald, RL; Munoz, D; Sacher, A; Wollmann, R | 1 |
Gizewski, ER; Lanzman, RS; Mathys, C; Mödder, U; Rapp, M; Ringelstein, A; Sabel, M; Saleh, A; Schroeteler, J; Turowski, B | 1 |
Alexiou, GA; Moschovi, M; Prodromou, C; Prodromou, N; Sfakianos, G; Stefanaki, K | 1 |
Aoyama, H; Hayashi, S; Hoshi, H; Iwama, T; Kanematsu, M; Matsuo, M; Miwa, K; Nishibori, H; Shinoda, J; Tanaka, O; Tsuge, Y; Yamada, J; Yano, H | 1 |
Cho, G; Cho, JH; Choi, N; Hong, KS; Kim, SM; Lee, C; Ryu, EK | 1 |
Gibbs-Strauss, SL; Jack Hoopes, P; Kauppinen, RA; Khan Hekmatyar, S; O'Hara, JA; Pogue, BW; Samkoe, KS; Yang, HH | 1 |
Bigner, DD; Brady, M; Choi, BD; Friedman, AH; Mehta, AI; Pastan, I; Raghavan, R; Sampson, JH | 1 |
Aloy, MT; Armandy, E; Barberi-Heyob, M; Bechet, D; Dutreix, M; Huger, S; Humbert, L; Le Duc, G; Lux, F; Mignot, A; Mowat, P; Perriat, P; Rima, W; Rodriguez-Lafrasse, C; Roulin, C; Roux, S; Tillement, O | 1 |
Imai, S; Ishida, M; Matsusue, Y; Mori, K; Shimizu, J; Taga, T | 1 |
Jafari-Khouzani, K; Mikkelsen, T; Najafi, M; Scarpace, L; Soltanian-Zadeh, H | 1 |
Pillai, JJ; Zacà, D | 1 |
Angel, P; Brockschmidt, A; Brockschmidt, FF; Ehrler, M; Grassmann, H; Hans, VH; Hoischen, A; Jugold, M; Kalla, C; Knolle, PA; Latz, E; Peterziel, H; Pfeifer, A; Pfenning, PN; Seifert, G; Trost, D; Waha, A; Weber, RG; Wick, W; Wohlleber, D; Zimmermann, K | 1 |
Arosio, D; Bartolomeo, MP; Belvisi, L; Bianchi, A; Brioschi, C; Buonsanti, F; Cabella, C; Casagrande, C; Civera, M; De Matteo, M; Fugazza, L; Lattuada, L; Maisano, F; Manzoni, L; Miragoli, L; Neira, C; Pilkington-Miksa, M; Scolastico, C | 1 |
Coenen, HH; Eble, MJ; Filss, CP; Fink, GR; Galldiks, N; Holy, R; Kaiser, HJ; Langen, KJ; Nolte, KW; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
Filss, C; Glas, M; Hadizadeh, DR; Herrlinger, U; Kuchelmeister, K; Langen, KJ; Mack, F; Pietsch, T; Schäfer, N; Schüller, H; Scorzin, J; Simon, M; Stuplich, M; Urbach, H | 1 |
Aguiar, PH; Cardoso, EF; Cerri, GG; Leite, CC; Lima, EC; Otaduy, MC; Pincerato, R; Rosemberg, S; Tsunemi, M | 1 |
Faucher, L; Fortin, MA; Gossuin, Y; Lagueux, J; Tremblay, M | 1 |
Owens, K; Yasui, L | 1 |
Bergmann, K; Bernado, L; Blasco, G; Daunis-I-Estadella, J; Essig, M; Joly, C; Laguillo, G; Pedraza, S; Puig, J; Quiles, AM; Remollo, S; Sánchez-González, J | 1 |
Davalos, RV; Ellis, TL; Garcia, PA; Johnson, AJ; Olson, JD; Robertson, JL; Rossmeisl, JH | 1 |
Hong, S; Im, K; Kang, JH; Kang, M; Lee, J; Lee, TS; Lim, SM; Park, S; Ryu, J; Song, R | 1 |
De Stasio, G; Franz, T; Frazer, BH; Girasole, M; Wiese, LM | 1 |
Iwama, T; Miwa, K; Nakashima, T; Okumura, A; Sakai, N; Shinoda, J; Yano, H | 1 |
Cannara, RJ; Casalbore, P; Crawford, JF; Daniels, MJ; De Stasio, G; Erhardt, RJ; Fowler, JF; Frazer, BH; Gilbert, B; Gilles, MK; Howard, SP; Larocca, LM; Mehta, MP; Mercanti, D; Pallini, R; Rajesh, D; Richter, KL; Schaub, S; Sonderegger, BR; Tyliszczak, T; Wiese, LM | 1 |
Erdoğan, N; Kurtsoy, A; Mavili, E; Menkü, A; Tucer, B | 1 |
Bartolini, A; Cerase, A; Esposito, G; Muccio, CF | 1 |
Anzai, Y; Black, KL; DeSalles, A; Farahani, K; Hamilton, DR; Lufkin, R | 1 |
Albert, F; Forsting, M; Kunze, S; Meyding-Lamadé, U; Sartor, K | 1 |
Albert, FK; Balzer, T; Forsting, M; Hartmann, M; Jansen, O; Sartor, K | 1 |
Andersen, C; Mühler, A; Rehling, M; Taagehøj, JF | 1 |
Ang, KK; Hazle, JD; Langford, LA; Leeds, NE; Price, RE; Stephens, LC; Tinkey, PT | 1 |
Holodny, AI; Petraikin, AV; Pronin, IN | 1 |
Clark, MC; Goldgof, DB; Hall, LO; Murtagh, FR; Silbiger, MS; Velthuizen, R | 1 |
Braun, I; Bussière, M; Fitzek, MM; Harsh, GR; Hedley-Whyte, ET; Hochberg, FH; Lev, MH; Liebsch, NJ; Munzenrider, JE; Okunieff, P; Pardo, FS; Rabinov, JD; Thornton, AF | 1 |
Hoult, DI; Kaibara, T; Louw, D; Saunders, J; Sutherland, GR; Tomanek, B | 1 |
Andres, R; Casalbore, P; De Stasio, G; Gilbert, B; Hansen, R; Margaritondo, G; Mercanti, D; Perfetti, L; Perfetti, P | 1 |
Casalbore, P; Ciotti, MT; De Stasio, G; Festinesi, A; Gilbert, B; Larocca, LM; Mehta, MP; Mercanti, D; Mogk, DW; Pallini, R; Perfetti, P; Perret, D; Rinelli, A; Rosi, G; Sanità, F | 1 |
Benderbous, S; Corot, C; Décorps, M; Dupeyre, R; Farion, R; Fonchy, E; François-Joubert, A; Lahrech, H; Rémy, C; Rubin, C | 1 |
Cosgrove, GR; Drislane, FW; Lam, CH; Sotrel, A | 1 |
Bydder, GM; Peterman, SB; Steiner, RE; Thomas, DJ; Tobias, JS; Young, IR | 1 |
4 review(s) available for gadolinium and Glioblastoma
Article | Year |
---|---|
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
Topics: Adult; Amino Acids; Brain Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Neurosurgeons; Positron-Emission Tomography; Practice Guidelines as Topic | 2022 |
The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
Topics: Adult; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Evidence-Based Medicine; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2014 |
Imaging of convection enhanced delivery of toxins in humans.
Topics: Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Convection; Drug Delivery Systems; Gadolinium; Glioblastoma; Humans; Immunotoxins; Liposomes; Magnetic Resonance Imaging; Tissue Distribution | 2011 |
Spinal glioblastoma multiforme of the conus medullaris with holocordal and intracranial spread in a child: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cauda Equina; Child; Combined Modality Therapy; Contrast Media; Fatal Outcome; Female; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Radiotherapy; Spinal Cord Neoplasms | 2012 |
5 trial(s) available for gadolinium and Glioblastoma
Article | Year |
---|---|
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Topics: Algorithms; Brain; Brain Neoplasms; Contrast Media; Deep Learning; Diffusion Magnetic Resonance Imaging; Disease Progression; Feasibility Studies; Gadolinium; Germany; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasms; Neural Networks, Computer; Prognosis; Radiology; Retrospective Studies; Tumor Burden | 2021 |
Albumin-binding MR blood pool contrast agent improves diagnostic performance in human brain tumour: comparison of two contrast agents for glioblastoma.
Topics: Albumins; Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study.
Topics: Adult; Aged; Brain Neoplasms; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[Does the administration of a high dose of a paramagnetic contrast medium (Gadovist) improve the diagnostic value of magnetic resonance tomography in glioblastomas?].
Topics: Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Supratentorial Neoplasms | 1996 |
Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Brain Neoplasms; Cobalt Radioisotopes; Contrast Media; Dose Fractionation, Radiation; Female; Follow-Up Studies; Gadolinium; Glioblastoma; Humans; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiopharmaceuticals; Supratentorial Neoplasms; Survival Rate | 1999 |
81 other study(ies) available for gadolinium and Glioblastoma
Article | Year |
---|---|
Does interventional MRI-guided brain cryotherapy cause a blood-brain barrier disruption? Radiological analysis and perspectives.
Topics: Blood-Brain Barrier; Brain; Brain Neoplasms; Contrast Media; Cryotherapy; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Interventional; Retrospective Studies | 2022 |
The TRUTH confirmed: validation of an intraindividual comparison of gadobutrol and gadoteridol for imaging of glioblastoma using quantitative enhancement analysis.
Topics: Artificial Intelligence; Contrast Media; Cross-Over Studies; Gadolinium; Glioblastoma; Heterocyclic Compounds; Humans; Organometallic Compounds | 2021 |
Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast Agent.
Topics: Animals; Contrast Media; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Rats; Tissue Distribution; Water; Zinc | 2022 |
Standard deviations of MR signal intensities show a consistent trend during imaging follow-ups for glioblastoma patients when corrected for non-biological heterogeneity due to hardware and software variation.
Topics: Brain Neoplasms; Follow-Up Studies; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Reproducibility of Results; Retrospective Studies; Software | 2023 |
Stem cell-nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy.
Topics: Animals; Gadolinium; Glioblastoma; Nanomedicine; Neutron Capture Therapy; Neutrons; Precision Medicine; Rats; Stem Cells; Tissue Distribution | 2023 |
Radiosensitization with Gadolinium Chelate-Coated Gold Nanoparticles Prevents Aggressiveness and Invasiveness in Glioblastoma.
Topics: Cell Line, Tumor; Chelating Agents; Contrast Media; Gadolinium; Glioblastoma; Gold; Humans; Metal Nanoparticles | 2023 |
Intracerebral gadolinium deposition following blood-brain barrier disturbance in two different mouse models.
Topics: Animals; Blood-Brain Barrier; Chromatography, Liquid; Contrast Media; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Glioblastoma; Globus Pallidus; Magnetic Resonance Imaging; Mice; Organometallic Compounds; Prospective Studies; Retrospective Studies; Tandem Mass Spectrometry | 2023 |
Met-PET uptake index for total tumor resection: identification of
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Tumor Burden | 2021 |
Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial Imaging Study.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiotherapy, Image-Guided; Tumor Burden; Young Adult | 2021 |
Multiscale Selectivity and in vivo Biodistribution of NRP-1
Topics: Animals; Endothelial Cells; Gadolinium; Glioblastoma; Humans; Molecular Targeted Therapy; Nanoparticles; Neoplasm Metastasis; Neuropilin-1; Photochemotherapy; Porphyrins; Precision Medicine; Rats; Theranostic Nanomedicine; Tissue Distribution | 2020 |
Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
Topics: Aged; Central Nervous System Neoplasms; Diagnosis, Differential; Female; Gadolinium; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Motion; ROC Curve | 2020 |
Synthesis and tumour cell uptake studies of gadolinium(III)-phosphonium complexes.
Topics: Antineoplastic Agents; Cell Proliferation; Gadolinium; Glioblastoma; Humans; Organophosphorus Compounds; Tissue Distribution; Tumor Cells, Cultured | 2021 |
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.
Topics: Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Gadolinium; Glioblastoma; Humans; Temozolomide; Treatment Outcome | 2021 |
Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biophysical Phenomena; Brain Neoplasms; Clinical Decision-Making; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Models, Theoretical; Neoplasm Invasiveness; Retrospective Studies; Tumor Burden; Young Adult | 2017 |
Differentiating enhancing multiple sclerosis lesions, glioblastoma, and lymphoma with dynamic texture parameters analysis (DTPA): A feasibility study.
Topics: Brain Neoplasms; Contrast Media; Diagnosis, Differential; Feasibility Studies; Gadolinium; Gadolinium DTPA; Glioblastoma; Humans; Image Enhancement; Lymphoma; Magnetic Resonance Imaging; Multiple Sclerosis | 2017 |
The dosimetric impact of gadolinium-based contrast media in GBM brain patient plans for a MRI-Linac.
Topics: Algorithms; Brain Neoplasms; Contrast Media; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Particle Accelerators; Phantoms, Imaging; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tumor Burden | 2017 |
Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients.
Topics: Adult; Aged; Blood-Brain Barrier; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Supratentorial Neoplasms | 2018 |
Fast magnetic resonance fingerprinting for dynamic contrast-enhanced studies in mice.
Topics: Algorithms; Animals; Brain; Brain Mapping; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Dysprosium; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Linear Models; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Phantoms, Imaging | 2018 |
Post-gadolinium 3-dimensional spatial, surface, and structural characteristics of glioblastomas differentiate pseudoprogression from true tumor progression.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Gadolinium; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis | 2018 |
Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma.
Topics: Animals; Brain; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Perfusion; Pyruvic Acid; Rats, Nude; Xenograft Model Antitumor Assays | 2019 |
Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.
Topics: Adult; Brain Neoplasms; Contrast Media; Female; Ferrosoferric Oxide; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies | 2019 |
Dissociation Between 11C-Methionine-Positron Emission Tomography and Gadolinium-Enhanced Magnetic Resonance Imaging in Longitudinal Features of Glioblastoma After Postoperative Radiotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Postoperative Care; Retrospective Studies; Temozolomide; Treatment Outcome | 2019 |
Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Genotype; Genotyping Techniques; Glioblastoma; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Grading; Retrospective Studies; Sensitivity and Specificity; Software | 2019 |
5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
Topics: Aminolevulinic Acid; Brain Neoplasms; Gadolinium; Glioblastoma; Humans; Optical Imaging; Positron-Emission Tomography; Tyrosine | 2019 |
Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Abscess; Brain Neoplasms; Child; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Young Adult | 2019 |
Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Edema; Brain Neoplasms; Cerebrovascular Circulation; Diffusion; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Time Factors | 2013 |
Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map.
Topics: Adult; Aged; Algorithms; Animals; Boron Neutron Capture Therapy; Brain Neoplasms; Diffusion; Female; Gadolinium; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Rats; Rats, Inbred F344; Retrospective Studies; Time Factors; Treatment Outcome | 2013 |
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden; Young Adult | 2013 |
Fatal glioblastoma after Gamma Knife radiosurgery for arteriovenous malformation in a child.
Topics: Arteriovenous Malformations; Brain Neoplasms; Cerebral Angiography; Child, Preschool; Contrast Media; Fatal Outcome; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Neoplasms, Radiation-Induced; Photomicrography; Radiosurgery; Tomography, X-Ray Computed | 2014 |
3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Chemoradiotherapy; Choline; Contrast Media; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Gadolinium; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Matched-Pair Analysis; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy Dosage; Temozolomide; Time Factors | 2014 |
A New Interleukin-13 Amino-Coated Gadolinium Metallofullerene Nanoparticle for Targeted MRI Detection of Glioblastoma Tumor Cells.
Topics: Amination; Animals; Cell Line, Tumor; Contrast Media; Fullerenes; Gadolinium; Glioblastoma; Humans; Interleukin-13; Magnetic Resonance Imaging; Mice, Nude; Models, Molecular; Nanoparticles | 2015 |
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
Topics: Aged; Biomarkers, Tumor; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Receptors, GABA; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2015 |
Pseudoprogression in a Patient With Glioblastoma Presenting as a Neurosurgical Emergency.
Topics: Brain Neoplasms; Disease Progression; Emergency Medical Services; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures | 2015 |
Magnetic resonance diffusion metrics indexing high focal cellularity and sharp transition at the tumour boundary predict poor outcome in glioblastoma multiforme.
Topics: Brain; Brain Neoplasms; Contrast Media; Diffusion Tensor Imaging; Female; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Proportional Hazards Models; Reproducibility of Results; Survival Analysis | 2015 |
High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.
Topics: Biomarkers; Brain Neoplasms; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Prospective Studies; Survival Rate | 2016 |
Investigating tumor perfusion by hyperpolarized
Topics: Animals; Brain Neoplasms; Carbon Isotopes; Contrast Media; Gadolinium; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Rats; Rats, Nude | 2017 |
Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent.
Topics: Animals; Brain; Brain Neoplasms; Contrast Media; Fluorides; Gadolinium; Glioblastoma; Hydrogen-Ion Concentration; Kidney; Kidney Neoplasms; Magnetic Resonance Imaging; Mice; Nanoparticles; Polylysine; Rats | 2016 |
High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function.
Topics: Adult; Brain Neoplasms; Contrast Media; Gadolinium; Glioblastoma; Humans; Kidney; Magnetic Resonance Imaging; Skin; Young Adult | 2016 |
Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells.
Topics: Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Gadolinium; Glioblastoma; Humans; Metal Nanoparticles | 2016 |
Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
Topics: Age Factors; Aged; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm, Residual; Postoperative Period; Predictive Value of Tests; Preoperative Period; Retrospective Studies; Survival Rate; Tumor Burden | 2017 |
Heterogeneous intratumoral distribution of gadolinium nanoparticles within U87 human glioblastoma xenografts unveiled by micro-PIXE imaging.
Topics: Animals; Contrast Media; Female; Gadolinium; Glioblastoma; Heterografts; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Nanoparticles; Spectrometry, X-Ray Emission; Tissue Distribution; Tumor Cells, Cultured | 2017 |
Gadolinium neutron capture in glioblastoma multiforme cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Survival; Gadolinium; Gadolinium DTPA; Gamma Rays; Glioblastoma; Humans; Neutrons | 2008 |
Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.
Topics: Adult; Aged; Female; Gadolinium; Glioblastoma; Humans; Hypoxia; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Survival Analysis; Tumor Burden | 2009 |
Evolution of glioblastoma.
Topics: Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis | 2009 |
Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
Topics: Adult; Brain Neoplasms; Cell Division; Computer Simulation; Contrast Media; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Neoplasm Invasiveness; Positron-Emission Tomography | 2009 |
Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Survival Analysis | 2010 |
Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
Topics: Adult; Aged; Blood Volume; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Disease Progression; Female; Ferrosoferric Oxide; Gadolinium; Glioblastoma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Organometallic Compounds; Pilot Projects; Young Adult | 2011 |
Long-term survival of a patient with glioblastoma.
Topics: Brain Neoplasms; DNA Modification Methylases; Gadolinium; Glioblastoma; HeLa Cells; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Survival | 2010 |
[Evaluation of ADC mapping as an early predictor for tumor response to chemotherapy in recurrent glioma treated with bevacizumab/irinotecan: proof of principle].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain; Brain Neoplasms; Camptothecin; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Gadolinium; Glioblastoma; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Irinotecan; Male; Neoplasm Recurrence, Local; Sensitivity and Specificity; Vascular Endothelial Growth Factor A | 2010 |
Malignant progression of a pleomorphic xanthoastrocytoma in a child.
Topics: Astrocytoma; Brain Neoplasms; Child, Preschool; Disease Progression; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed | 2010 |
Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Spiral Computed; Tumor Burden; Young Adult | 2012 |
The use of the fusion protein RGD-HSA-TIMP2 as a tumor targeting imaging probe for SPECT and PET.
Topics: Animals; Cell Line, Tumor; Gadolinium; Glioblastoma; Humans; Iodine Radioisotopes; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Oligopeptides; Positron-Emission Tomography; Recombinant Fusion Proteins; Serum Albumin; Tissue Inhibitor of Metalloproteinase-2; Tomography, Emission-Computed, Single-Photon | 2011 |
Protoporphyrin IX fluorescence contrast in invasive glioblastomas is linearly correlated with Gd enhanced magnetic resonance image contrast but has higher diagnostic accuracy.
Topics: Aminolevulinic Acid; Animals; Area Under Curve; Cell Line, Tumor; Diffusion; Gadolinium; Glioblastoma; Histocytochemistry; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Protoporphyrins; ROC Curve; Spectrometry, Fluorescence | 2011 |
In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Comet Assay; DNA Damage; Gadolinium; Glioblastoma; Humans; In Vitro Techniques; Nanoparticles; Radiation-Sensitizing Agents | 2011 |
Prediction of glioblastoma multiform response to bevacizumab treatment using multi-parametric MRI.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Edema; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Prognosis; Regression Analysis; Survival Analysis; Treatment Outcome; Tumor Burden | 2012 |
Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
Topics: Brain; Brain Mapping; Brain Neoplasms; Breath Holding; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Oligodendroglioma; Oxygen; Perfusion Imaging; Retrospective Studies | 2012 |
KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.
Topics: Animals; Animals, Newborn; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Comparative Genomic Hybridization; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Female; Focal Adhesions; Gadolinium; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Green Fluorescent Proteins; Humans; Immunoprecipitation; In Vitro Techniques; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Neuroglia; Neurons; RNA, Messenger; Transfection; Tumor Stem Cell Assay; Tumor Suppressor Proteins; Vinculin; Xenograft Model Antitumor Assays | 2012 |
Synthesis of Gd and (68)Ga complexes in conjugation with a conformationally optimized RGD sequence as potential MRI and PET tumor-imaging probes.
Topics: Animals; Cell Line, Tumor; Coordination Complexes; Gadolinium; Gallium Radioisotopes; Glioblastoma; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Models, Molecular; Oligopeptides; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Transplantation, Heterologous | 2012 |
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Contrast Media; Disease Progression; Disease-Free Survival; Female; Gadolinium; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tyrosine | 2012 |
Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Dacarbazine; Disease Progression; Fatal Outcome; Female; Gadolinium; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Radiotherapy, Adjuvant; Temozolomide; Treatment Outcome | 2012 |
The effect of paramagnetic contrast in choline peak in patients with glioblastoma multiforme might not be significant.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Choline; Contrast Media; Electron Spin Resonance Spectroscopy; Female; Gadolinium; Glioblastoma; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cell Tracking; Contrast Media; Gadolinium; Glioblastoma; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice; Particle Size; Polyethylene Glycols; Rats; Transplantation, Heterologous | 2012 |
Necrosis is not induced by gadolinium neutron capture in glioblastoma multiforme cells.
Topics: Autophagy; Cell Line, Tumor; Cell Survival; Gadolinium; Glioblastoma; Humans; Necrosis; Neutron Capture Therapy | 2012 |
7.0-T magnetic resonance imaging characterization of acute blood-brain-barrier disruption achieved with intracranial irreversible electroporation.
Topics: Ablation Techniques; Animals; Biological Transport; Blood-Brain Barrier; Disease Susceptibility; Electroporation; Gadolinium; Glioblastoma; Magnetic Resonance Imaging; Male; Rats; Rats, Inbred F344; Skull | 2012 |
RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis.
Topics: Animals; Cell Line, Tumor; Dimerization; Erbium; Feasibility Studies; Fluorides; Gadolinium; Glioblastoma; Humans; Integrin alphaVbeta3; Iodine Radioisotopes; Luminescent Agents; Luminescent Measurements; Magnetic Resonance Imaging; Mice; Molecular Imaging; Nanostructures; Neovascularization, Pathologic; Oligopeptides; Polyethylene Glycols; Positron-Emission Tomography; Ytterbium | 2013 |
Spectromicroscope for the PHotoelectron Imaging of Nanostructures with X-rays (SPHINX): performance in biology, medicine and geology.
Topics: Cyanobacteria; Electrons; Gadolinium; Glioblastoma; Humans; Microscopy; Phosphorus; Spectrum Analysis; X-Rays | 2004 |
Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
Topics: Animals; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Gadolinium; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mass Spectrometry; Neoplasm Transplantation; Neutron Capture Therapy; Pentetic Acid; Radiography; Radioisotopes; Radionuclide Imaging; Rats; Time Factors; Tissue Distribution | 2005 |
Ultrasound guidance in intracranial tumor resection: correlation with postoperative magnetic resonance findings.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Intraoperative Period; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Postoperative Period; Treatment Outcome; Ultrasonography | 2005 |
Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Brain Abscess; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Organometallic Compounds; Toxoplasmosis, Cerebral | 2008 |
Preliminary experience with MR-guided thermal ablation of brain tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Feasibility Studies; Feedback; Follow-Up Studies; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Oligodendroglioma; Patient Care Planning; Radiology, Interventional; Radiosurgery; Treatment Outcome | 1995 |
Accelerated methaemoglobin formation: potential pitfall in early postoperative MRI.
Topics: Brain; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Gadolinium DTPA; Glioblastoma; Hemoglobins; Hemostatics; Humans; Hydrogen Peroxide; Image Enhancement; Magnetic Resonance Imaging; Male; Methemoglobin; Middle Aged; Organometallic Compounds; Oxidation-Reduction; Pentetic Acid; Postoperative Care; Prospective Studies; Time Factors; Tomography, X-Ray Computed | 1993 |
Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves.
Topics: Adenocarcinoma; Algorithms; Blood-Brain Barrier; Brain Neoplasms; Cerebral Arteries; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Glioblastoma; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Spectrum Analysis; Technetium Tc 99m Pentetate; Teratoma | 1996 |
Glioblastoma multiforme arising in the irradiated spinal cord of a rhesus monkey (Macaca mulatta).
Topics: Animals; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Glioblastoma; Macaca mulatta; Magnetic Resonance Imaging; Neoplasms, Radiation-Induced; Organometallic Compounds; Pentetic Acid; Primate Diseases; Radiation Injuries, Experimental; Spinal Cord; Spinal Cord Injuries; Spinal Cord Neoplasms | 1996 |
MRI of high-grade glial tumors: correlation between the degree of contrast enhancement and the volume of surrounding edema.
Topics: Adult; Aged; Astrocytoma; Blood-Brain Barrier; Brain Edema; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Pentetic Acid | 1997 |
Automatic tumor segmentation using knowledge-based techniques.
Topics: Algorithms; Artificial Intelligence; Brain; Brain Neoplasms; Contrast Media; Expert Systems; False Positive Reactions; Gadolinium; Glioblastoma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meninges; Pattern Recognition, Automated; Radiology; Sensitivity and Specificity; Subtraction Technique | 1998 |
A mobile high-field magnetic resonance system for neurosurgery.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cranial Nerve Neoplasms; Evaluation Studies as Topic; Female; Gadolinium; Glioblastoma; Humans; Intraoperative Period; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurilemmoma; Neurosurgery; Olfactory Nerve Diseases; Oligodendroglioma; Operating Rooms | 1999 |
UV-ozone ashing of cells and tissues for spatially resolved trace element analysis.
Topics: Carbon; Central Nervous System Neoplasms; Gadolinium; Glioblastoma; Humans; Meningeal Neoplasms; Meningioma; Microscopy, Electron; Ozone; Spectrophotometry; Trace Elements; Tumor Cells, Cultured; Ultraviolet Rays | 2000 |
Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy.
Topics: Cell Death; Cell Membrane; Cell Nucleus; Cytoplasm; Gadolinium; Gadolinium DTPA; Glioblastoma; Humans; Isotopes; Mass Spectrometry; Neutron Capture Therapy; Spectrometry, X-Ray Emission; Tumor Cells, Cultured | 2001 |
A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: kinetic study on a C6 rat glioma model.
Topics: Animals; Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2001 |
Spinal leptomeningeal metastasis from cerebral glioblastoma. Appearance on magnetic resonance imaging.
Topics: Aged; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Neoplasm Seeding; Organometallic Compounds; Pentetic Acid; Spinal Cord Neoplasms | 1991 |
Nuclear magnetic resonance imaging (NMR), (MRI), of brain stem tumours.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pentetic Acid; Tomography, X-Ray Computed | 1985 |